| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/18/2004 | US20040054130 Insulin potentiating peptides |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053823 Polypeptides with amino acid sequences or peptidomimetics |
| 03/18/2004 | US20040053820 Histone deacetylase inhibitor |
| 03/18/2004 | US20040053775 Combinatorial approach to chiral reagents or catalysts having amine or amino alcohol ligands |
| 03/18/2004 | US20040053330 Amino polyols and amino sugars |
| 03/18/2004 | US20040053323 Method of screening inducible nitric oxide synthase activation inhibitor |
| 03/18/2004 | US20040052928 A peptide containing at least 5 amino acid residues and less than 15 amino acid residues; |
| 03/18/2004 | US20040052820 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 03/18/2004 | DE10239832A1 New sarcolysine derivatives, e.g. amide or peptide compounds, useful as anticancer agents with reduced toxicity to healthy cells |
| 03/18/2004 | CA2536010A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | CA2535792A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | CA2535788A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | CA2497991A1 Fluorescent enzyme assay methods and compositions |
| 03/18/2004 | CA2497477A1 Method of designing physiologically active peptide and use thereof |
| 03/17/2004 | EP1398030A2 Dipeptidyl peptidase IV effectors |
| 03/17/2004 | EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 03/17/2004 | EP0951471B1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 03/17/2004 | EP0948523B1 Peptidomimetic inhibitors of the human cytomegalovirus protease |
| 03/16/2004 | US6706862 Backbone-cyclized BPI peptidomimetics |
| 03/16/2004 | US6706742 Alpha-amino-acid compounds |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706304 Granular sweetener |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020460A1 Novel depsipeptide compound |
| 03/11/2004 | WO2004020402A1 Sulphonylamino derivatives for the treatment of alzheimer's disease |
| 03/11/2004 | WO2004020397A1 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 03/11/2004 | WO2004019983A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/11/2004 | WO2003097587A3 Gelling agents |
| 03/11/2004 | WO2003066587A3 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists |
| 03/11/2004 | WO2003062247A3 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 03/11/2004 | WO2003040172A3 Methods and reagents for peptide-bir interaction screens |
| 03/11/2004 | WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 03/11/2004 | US20040049066 N-(N-(3-(3-methoxy-4-hydroxyphenyl)propyl)-L-alpha-aspartyl)-L -phenylalanine 1-methyl ester prepared by reacting aspartame with 3-(3-methoxy-4-hydroxyphenyl) propionaldehyde; artificial sweetener |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048802 Hepatitis C virus inhibitors |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048788 Sh2 domain binding inhibitors |
| 03/11/2004 | US20040048327 Aza-peptide epoxides |
| 03/11/2004 | US20040048243 Identifying peptides by obtaining a sample, exposing it to a phage display library recovering bound substances; use in gene therapy vectors and in diagnosis and treatment of cancer |
| 03/11/2004 | DE10240452A1 New (hetero)aryl-guanidine or -amidine compounds, are potent and selective urokinase-plasminogen activator inhibitors, useful for treating tumors or metastasis formation |
| 03/11/2004 | CA2497281A1 Novel depsipeptide compound |
| 03/11/2004 | CA2496745A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396270A1 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 03/10/2004 | EP1396269A1 Boronic acid salts of multivalent metals used in the preparation of a medicament for treating thrombosis |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP0918547B1 Radiolabeled annexins |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/09/2004 | US6703483 Peptides and their analogs for use in management of pain during labor |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703362 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
| 03/09/2004 | US6703020 Antibody conjugate methods for selectively inhibiting VEGF |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018503A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | WO2004018502A1 Compounds binding to p-selectin |
| 03/04/2004 | WO2004018498A2 Minicell display and products therefrom |
| 03/04/2004 | WO2003101391A3 Therapeutic methods |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2002038540A9 Activity-dependent cysteine protease profiling reagent |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040043939 Peptide-based gemini compounds |
| 03/04/2004 | US20040043472 Novel substances k97-0239 and process for producing the same |
| 03/04/2004 | CA2496215A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | CA2493471A1 Compounds binding to p-selectin |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1392841A2 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process |
| 03/03/2004 | EP1392721A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease |
| 03/03/2004 | EP1392720A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392346A2 Composition and method for enhancing elasticity of tissue |
| 03/03/2004 | EP1076645B1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | EP0832900B1 Peptide and method of obtaining it |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/02/2004 | US6699973 Gastro-intestinal tract (git); used to determine fate of drugs attached to git-targeting agents |
| 03/02/2004 | US6699897 Streptogramin derivatives, their preparation and compositions which contain them |
| 03/02/2004 | US6699869 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/26/2004 | WO2004005328A3 Peptidomimetic compound useful as inhibitor of integrins |
| 02/26/2004 | WO2003104217A3 Prodrugs of excitatory amino acids |
| 02/26/2004 | WO2003095474A3 Peptides and methods for the control of obesity |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003051837A3 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 02/26/2004 | WO2003029495A3 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002053172A3 Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover |